{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:44:38Z","timestamp":1775011478354,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diagnosing Ehlers-Danlos syndromes (EDS) and EDS-related \u201chypermobility spectrum disorder\u201d (HSD) is challenging and cutaneous manifestations often serve as indicators of these rare connective tissue disorders. Only limited data exist on the healthcare of EDS\/HSD in Germany as specialized services have been missing and a national register is not available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>In 2020, a dermatologic-orthopedic EDS outpatient service was initiated at the University Hospital of Cologne, Germany. The objectives of the present survey were to examine the \u201cmedical journey\u201d and the disease burden of our patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A pseudonymized paper survey was sent to all adults who were diagnosed with hypermobile EDS (hEDS), classical EDS (cEDS), classical-like EDS (clEDS) or generalized HSD at the EDS Cologne service from December 2021 until May 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 99 participants, 80 were diagnosed with hEDS\/HSD, 16 with cEDS and 3 with clEDS. The mean time to diagnosis was 22.0 years (14.5 years for cEDS\/clEDS vs. 23.0 years for hEDS\/HSD). 24.2% of the participants had a recognized degree of disability of \u2265\u200950, the average sick leave in the last 3 months was 4.6 days for cEDS\/clEDS and 21.3 days for hEDS\/HSD. 44.9% of the hEDS\/HSD patients reported on having at least four comorbidities compared to 21.1% in the cEDS\/clEDS group (<jats:italic>p<\/jats:italic>\u2009=\u20090.023). At least 15 medical specialties were involved in the diagnostics and treatment of participants with multiple therapeutic modalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first study providing an insight on the healthcare supply of EDS\/HSD patients in Germany. Participants in our survey had a much longer \u201cdiagnostic journey\u201d than the one in previous studies and suffered from high morbidity despite high healthcare utilization. Our results point to the urgent necessity of a better coordinated, multidisciplinary care for patients with these complex genodermatoses including innovative political structures, further research and international networking.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03937-4","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T15:44:31Z","timestamp":1755359071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9796-1235","authenticated-orcid":false,"given":"Jonas","family":"Rauterberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Kernich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arim","family":"Shukri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Klapproth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"L\u00f6w","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Henning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliana","family":"Tantcheva-Po\u00f3r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"1","key":"3937_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8\u201326.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"3937_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41572-020-0194-9","volume":"6","author":"F Malfait","year":"2020","unstructured":"Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, Byers PH. The Ehlers\u2013Danlos syndromes. Nat Rev Dis Primer. 2020;6(1):64.","journal-title":"Nat Rev Dis Primer"},{"key":"3937_CR3","unstructured":"Chernogubow AN. Uber einen fall von cutis Laxa. Jahresber Ges Med 27. 1892;562."},{"issue":"1","key":"3937_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2141.2008.06994.x","volume":"141","author":"LA Parapia","year":"2008","unstructured":"Parapia LA, Jackson C. Ehlers-Danlos syndrome\u2013 a historical review. Br J Haematol. 2008;141(1):32\u20135.","journal-title":"Br J Haematol"},{"issue":"3","key":"3937_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaad.2023.01.034","volume":"89","author":"BJ Doolan","year":"2023","unstructured":"Doolan BJ, Lavallee M, Hausser I, Pope FM, Seneviratne SL, Winship IM, et al. Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review. J Am Acad Dermatol. 2023;89(3):551\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3937_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajmg.c.31538","volume":"175","author":"B Tinkle","year":"2017","unstructured":"Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48\u201369.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"3937_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ajmg.c.31539","volume":"175","author":"M Castori","year":"2017","unstructured":"Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017;175(1):148\u201357.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"3937_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ajmg.a.61459","volume":"182","author":"L McGillis","year":"2020","unstructured":"McGillis L, Mittal N, Santa Mina D, So J, Soowamber M, Weinrib A, et al. Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers\u2013Danlos syndrome clinic: A retrospective review. Am J Med Genet A. 2020;182(3):484\u201392.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"3937_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00296-021-04968-3","volume":"41","author":"B Aubry-Rozier","year":"2021","unstructured":"Aubry-Rozier B, Schwitzguebel A, Valerio F, Tanniger J, Paquier C, Berna C, et al. Are patients with hypermobile Ehlers\u2013Danlos syndrome or hypermobility spectrum disorder so different? Rheumatol Int. 2021;41(10):1785\u201394.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3937_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ajmg.a.63426","volume":"194","author":"M Ritelli","year":"2024","unstructured":"Ritelli M, Chiarelli N, Cinquina V, Vezzoli M, Venturini M, Colombi M. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center. Am J Med Genet A. 2024;194(2):174\u201394.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3937_CR11","doi-asserted-by":"publisher","first-page":"e63857","DOI":"10.1002\/ajmg.a.63857","volume":"197","author":"M Ritelli","year":"2024","unstructured":"Ritelli M, Chiarelli N, Cinquina V, Bertini V, Piantoni S, Caproli A, et al. Bridging the diagnostic gap for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: evidence of a common extracellular matrix fragmentation pattern in patient plasma as a potential biomarker. Am J Med Genet A. 2024;197(1):e63857.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"3937_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/MOP.0000000000000541","volume":"29","author":"M Castori","year":"2017","unstructured":"Castori M, Hakim A. Contemporary approach to joint hypermobility and related disorders. Curr Opin Pediatr. 2017;29(6):640\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"11","key":"3937_CR13","doi-asserted-by":"publisher","first-page":"e031365","DOI":"10.1136\/bmjopen-2019-031365","volume":"9","author":"JC Demmler","year":"2019","unstructured":"Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case\u2013control comparison. BMJ Open. 2019;9(11):e031365.","journal-title":"BMJ Open"},{"issue":"1","key":"3937_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s42399-022-01218-w","volume":"5","author":"DRT Knight","year":"2022","unstructured":"Knight DRT, Confiado SM, Bruno KA, Fairweather D, Seymour-Sonnier AM, Jain A, et al. Establishing an Ehlers-Danlos syndrome clinic: lessons learned. SN Compr Clin Med. 2022;5(1):138.","journal-title":"SN Compr Clin Med"},{"issue":"1","key":"3937_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/08998280.2020.1805714","volume":"34","author":"B Song","year":"2021","unstructured":"Song B, Yeh P, Harrell J. Systemic manifestations of Ehlers-Danlos syndrome. Bayl Univ Med Cent Proc. 2021;34(1):49\u201353.","journal-title":"Bayl Univ Med Cent Proc"},{"issue":"5","key":"3937_CR16","first-page":"763","volume":"56","author":"ML Kulas S\u00f8borg","year":"2017","unstructured":"Kulas S\u00f8borg ML, Leganger J, Quitzau Mortensen L, Rosenberg J, Burcharth J. Establishment and baseline characteristics of a nationwide Danish cohort of patients with Ehlers\u2013Danlos syndrome. Rheumatology (Oxford). 2017;56(5):763\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3937_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jpainsymman.2019.05.013","volume":"58","author":"JR Schubart","year":"2019","unstructured":"Schubart JR, Schaefer E, Hakim AJ, Francomano CA, Bascom R. Use of cluster analysis to delineate symptom profiles in an Ehlers-Danlos syndrome patient population. J Pain Symptom Manage. 2019;58(3):427\u201336.","journal-title":"J Pain Symptom Manage"},{"key":"3937_CR18","unstructured":"EURODIS. The Voice of 12,000 Patients. Experiences and Expectations of Rare Disease Patients on Diagnosis and Care in Europe. EURORDIS - Rare Diseases Europe. 2009. Available from: https:\/\/www.eurordis.org\/wp-content\/uploads\/2009\/12\/EURORDISCARE_FULLBOOKr.pdf. Accessed 17 Jun 2025."},{"issue":"1","key":"3937_CR19","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.gimo.2023.100812","volume":"1","author":"CME Halverson","year":"2023","unstructured":"Halverson CME, Cao S, Perkins SM, Francomano CA. Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome. Genet Med Open. 2023;1(1):100812.","journal-title":"Genet Med Open"},{"key":"3937_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","volume":"32","author":"F Faye","year":"2024","unstructured":"Faye F, Crocione C, Anido de Pe\u00f1a R, Bellagambi S, Escati Pe\u00f1aloza L, Hunter A, et al. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a rare barometer retrospective patient survey. Eur J Hum Genet. 2024;32:1116\u201326.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"3937_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ajmg.c.31935","volume":"187","author":"CME Halverson","year":"2021","unstructured":"Halverson CME, Clayton EW, Garcia Sierra A, Francomano C. Patients with Ehlers\u2013Danlos syndrome on the diagnostic odyssey: rethinking complexity and difficulty as a hero\u2019s journey. Am J Med Genet C Semin Med Genet. 2021;187(4):416\u201324.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"9629","key":"3937_CR22","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","volume":"371","author":"S Aym\u00e9","year":"2008","unstructured":"Aym\u00e9 S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371(9629):2048\u201351.","journal-title":"Lancet"},{"issue":"4","key":"3937_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.c.31942","volume":"187","author":"L Bloom","year":"2021","unstructured":"Bloom L, Schubart J, Bascom R, Hakim A, Francomano CA. The power of patient-led global collaboration. Am J Med Genet C Semin Med Genet. 2021;187(4):425\u20138.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"3937_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.JAA.0000657160.48246.91","volume":"33","author":"E Miller","year":"2020","unstructured":"Miller E, Grosel JM. A review of Ehlers-Danlos syndrome. JAAPA. 2020;33(4):23\u20138.","journal-title":"JAAPA"},{"issue":"4","key":"3937_CR25","doi-asserted-by":"publisher","first-page":"e0034","DOI":"10.5041\/RMMJ.10261","volume":"7","author":"Y Gazit","year":"2016","unstructured":"Gazit Y, Jacob G, Grahame R. Ehlers-Danlos syndrome-hypermobility type: A much neglected multisystemic disorder. Rambam Maimonides Med J. 2016;7(4):e0034.","journal-title":"Rambam Maimonides Med J"},{"issue":"1","key":"3937_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-019-1075-8","volume":"14","author":"L Vandeborne","year":"2019","unstructured":"Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14(1):99.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"3937_CR27","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/nmo.12665","volume":"27","author":"AD Nelson","year":"2015","unstructured":"Nelson AD, Mouchli MA, Valentin N, Deyle D, Pichurin P, Acosta A, et al. Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo clinic. Neurogastroenterol Motil. 2015;27(11):1657\u201366.","journal-title":"Neurogastroenterol Motil"},{"key":"3937_CR28","unstructured":"Alliance Maladies Rares. ERRADIAG-L\u2019errance diagnostique dans le maladies rares. 2016.Available from: https:\/\/www.alliance-maladies-rares.org\/wp-content\/uploads\/2020\/05\/Erradiag-l-errance-diagnostic-dans-les-maladies-rares1.pdf. Accessed 17 Jun 2025."},{"issue":"1","key":"3937_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41467-019-08475-9","volume":"10","author":"D Westergaard","year":"2019","unstructured":"Westergaard D, Moseley P, S\u00f8rup FKH, Baldi P, Brunak S. Population-wide analysis of differences in disease progression patterns in men and women. Nat Commun. 2019;10(1):666.","journal-title":"Nat Commun"},{"issue":"1","key":"3937_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ajmg.c.31545","volume":"175","author":"RHH Engelbert","year":"2017","unstructured":"Engelbert RHH, Juul-Kristensen B, Pacey V, de Wandele I, Smeenk S, Woinarosky N, et al. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome\/hypermobile Ehlers Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):158\u201367.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"3937_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-023-02717-2","volume":"18","author":"LJ Tofts","year":"2023","unstructured":"Tofts LJ, Simmonds J, Schwartz SB, Richheimer RM, O\u2019Connor C, Elias E, et al. Pediatric joint hypermobility: a diagnostic framework and narrative review. Orphanet J Rare Dis. 2023;18(1):104.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3937_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13023-020-01470-0","volume":"15","author":"M Ritelli","year":"2020","unstructured":"Ritelli M, Venturini M, Cinquina V, Chiarelli N, Colombi M. Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives. Orphanet J Rare Dis. 2020;15(1):197.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3937_CR33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/ajmg.a.62672","volume":"188","author":"N Damseh","year":"2022","unstructured":"Damseh N, Dupuis L, O\u2019Connor C, Oh RY, Wang YW, Stavropoulos DJ, et al. Diagnostic outcomes for molecular genetic testing in children with suspected Ehlers-Danlos syndrome. Am J Med Genet A. 2022;188(5):1376\u201383.","journal-title":"Am J Med Genet A"},{"key":"3937_CR34","unstructured":"Bundesamt S. 7,9 Millionen schwerbehinderte Menschen leben in Deutschland. 2023. Available from: https:\/\/www.destatis.de\/DE\/Presse\/Pressemitteilungen\/2020\/06\/PD20_230_227.html. Accessed 17 Jun 2025."},{"key":"3937_CR35","unstructured":"Statistisches Bundesamt (Internet). Krankenstand. Anteil der erwerbst\u00e4tigen Bev\u00f6lkerung mit krankheitsbedingten Fehlzeiten. Available from: https:\/\/www.destatis.de\/DE\/Themen\/Arbeit\/Arbeitsmarkt\/Qualitaet-Arbeit\/Dimension-2\/krankenstand.html. Accessed 17 Jun 2025."},{"key":"3937_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12891-015-0549-7","volume":"16","author":"B Berglund","year":"2015","unstructured":"Berglund B, Pettersson C, Pigg M, Kristiansson P. Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire study. BMC Musculoskelet Disord. 2015;16:89.","journal-title":"BMC Musculoskelet Disord"},{"issue":"14","key":"3937_CR37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3109\/09638288.2015.1102336","volume":"38","author":"EC Johannessen","year":"2016","unstructured":"Johannessen EC, Reiten HS, L\u00f8vaas H, Maeland S, Juul-Kristensen B. Shoulder function, pain and health related quality of life in adults with joint hypermobility syndrome\/Ehlers-Danlos syndrome-hypermobility type. Disabil Rehabil. 2016;38(14):1382\u201390.","journal-title":"Disabil Rehabil"},{"issue":"8","key":"3937_CR38","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/ajmg.a.37774","volume":"170","author":"C Bovet","year":"2016","unstructured":"Bovet C, Carlson M, Taylor M. Quality of life, unmet needs, and iatrogenic injuries in rehabilitation of patients with Ehlers-Danlos syndrome hypermobility type\/joint hypermobility syndrome. Am J Med Genet A. 2016;170(8):2044\u201351.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"3937_CR39","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.apmr.2016.02.015","volume":"97","author":"MC Scheper","year":"2016","unstructured":"Scheper MC, Juul-Kristensen B, Rombaut L, Rameckers EA, Verbunt J, Engelbert RH. Disability in adolescents and adults diagnosed with hypermobility-related disorders: A meta-analysis. Arch Phys Med Rehabil. 2016;97(12):2174\u201387.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"3937_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00296-015-3375-1","volume":"36","author":"SA Hershenfeld","year":"2016","unstructured":"Hershenfeld SA, Wasim S, McNiven V, Parikh M, Majewski P, Faghfoury H, et al. Psychiatric disorders in Ehlers-Danlos syndrome are frequent, diverse and strongly associated with pain. Rheumatol Int. 2016;36(3):341\u20138.","journal-title":"Rheumatol Int"},{"issue":"1","key":"3937_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/rheumatology\/ket317","volume":"53","author":"TO Smith","year":"2014","unstructured":"Smith TO, Easton V, Bacon H, Jerman E, Armon K, Poland F, et al. The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysis. Rheumatology. 2014;53(1):114\u201322.","journal-title":"Rheumatology"},{"issue":"2","key":"3937_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000542026","volume":"241","author":"M Kernich","year":"2025","unstructured":"Kernich M, Peters F, Schreml J, Semmler O, Koch M, Sch\u00f6nau E, et al. Ehlers-Danlos syndromes and related disorders: diagnostic challenges and the need for an interdisciplinary patient care in Germany. Dermatology. 2025;241(2):124\u201332.","journal-title":"Dermatology"},{"issue":"1","key":"3937_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.c.31542","volume":"175","author":"A Hakim","year":"2017","unstructured":"Hakim A, De Wandele I, O\u2019Callaghan C, Pocinki A, Rowe P. Chronic fatigue in Ehlers-Danlos syndrome-hypermobile type. Am J Med Genet C Semin Med Genet. 2017;175(1):175\u201380.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3937_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.autneu.2018.02.006","volume":"215","author":"M Roma","year":"2018","unstructured":"Roma M, Marden CL, De Wandele I, Francomano CA, Rowe PC. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Auton Neurosci Basic Clin. 2018;215:89\u201396.","journal-title":"Auton Neurosci Basic Clin"},{"issue":"3","key":"3937_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-019-08755-8","volume":"58","author":"AH Kucharik","year":"2020","unstructured":"Kucharik AH, Chang C. The relationship between hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS). Clin Rev Allergy Immunol. 2020;58(3):273\u201397.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"3937_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ajmg.c.31938","volume":"187","author":"A Choudhary","year":"2021","unstructured":"Choudhary A, Fikree A, Aziz Q. Overlap between irritable bowel syndrome and hypermobile Ehlers-Danlos syndrome: an unexplored clinical phenotype? Am J Med Genet C Semin Med Genet. 2021;187(4):561\u20139.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"3937_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.c.31954","volume":"187","author":"AJ Hakim","year":"2021","unstructured":"Hakim AJ, Tinkle BT, Francomano CA. Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: reports from EDS ECHO. Am J Med Genet C Semin Med Genet. 2021;187(4):413\u20135.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"3937_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/cge.13653","volume":"97","author":"M Ritelli","year":"2020","unstructured":"Ritelli M, Rovati C, Venturini M, Chiarelli N, Cinquina V, Castori M, et al. Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology. Clin Genet. 2020;97(2):287\u201395.","journal-title":"Clin Genet"},{"key":"3937_CR49","doi-asserted-by":"publisher","first-page":"1365712","DOI":"10.3389\/fpubh.2024.1365712","volume":"12","author":"JR Schubart","year":"2024","unstructured":"Schubart JR, Schaefer EW, Knight DRT, Mills SE, Francomano CA. Estimates of the excess cost burden of Ehlers-Danlos syndromes: a United States MarketScan\u00ae claims database analysis. Front Public Health. 2024;12:1365712.","journal-title":"Front Public Health"},{"issue":"4","key":"3937_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ajmg.c.31958","volume":"187","author":"EA Yonko","year":"2021","unstructured":"Yonko EA, LoTurco HM, Carter EM, Raggio CL. Orthopedic considerations and surgical outcomes in Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2021;187(4):458\u201365.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"3937_CR51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.apmr.2011.01.016","volume":"92","author":"L Rombaut","year":"2011","unstructured":"Rombaut L, Malfait F, De Wandele I, Cools A, Thijs Y, De Paepe A, et al. Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers-Danlos syndrome. Arch Phys Med Rehabil. 2011;92(7):1106\u201312.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"3937_CR52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.a.61031","volume":"179","author":"JR Schubart","year":"2019","unstructured":"Schubart JR, Schilling A, Schaefer E, Bascom R, Francomano C. Use of prescription opioid and other drugs among a cohort of persons with Ehlers-Danlos syndrome: A retrospective study. Am J Med Genet A. 2019;179(3):397\u2013403.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"3937_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/mpr.1438","volume":"23","author":"S Mack","year":"2014","unstructured":"Mack S, Jacobi F, Gerschler A, Strehle J, H\u00f6fler M, Busch MA, et al. Self-reported utilization of mental health services in the adult German population\u2013evidence for unmet needs? Results of the DEGS1-Mental health module (DEGS1-MH). Int J Methods Psychiatr Res. 2014;23(3):289\u2013303.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"3937_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ajmg.c.31550","volume":"175","author":"AF Brady","year":"2017","unstructured":"Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017;175(1):70\u2013115.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"3937_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/09638288.2017.1398278","volume":"41","author":"JV Simmonds","year":"2019","unstructured":"Simmonds JV, Herbland A, Hakim A, Ninis N, Lever W, Aziz Q, et al. Exercise beliefs and behaviours of individuals with joint hypermobility syndrome\/Ehlers-Danlos syndrome - hypermobility type. Disabil Rehabil. 2019;41(4):445\u201355.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"3937_CR56","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ajmg.c.31551","volume":"175","author":"WB Ericson","year":"2017","unstructured":"Ericson WB, Wolman R. Orthopaedic management of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):188\u201394.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"3937_CR57","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/ajmg.a.36060","volume":"161A","author":"T Bathen","year":"2013","unstructured":"Bathen T, H\u00e5ngmann AB, Hoff M, Andersen L\u00d8, Rand-Hendriksen S. Multidisciplinary treatment of disability in ehlers-danlos syndrome hypermobility type\/hypermobility syndrome: A pilot study using a combination of physical and cognitive-behavioral therapy on 12 women. Am J Med Genet A. 2013;161A(12):3005\u201311.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"3937_CR58","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.apmr.2023.06.012","volume":"104","author":"A Hakimi","year":"2023","unstructured":"Hakimi A, Bergoin C, De Jesus A, Hoorelbeke A, Ramon P, Florea O, et al. Multiple sustainable benefits of a rehabilitation program in therapeutic management of hypermobile Ehlers-Danlos syndrome: A prospective and controlled study at short- and medium-term. Arch Phys Med Rehabil. 2023;104(12):2059\u201366.","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"3937_CR59","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1002\/ejp.70030","volume":"29","author":"MT Chew","year":"2025","unstructured":"Chew MT, Ilhan E, Nicholson LL, Kobayashi S, Pacey V, Hakim A, Chan C. HOPE for hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder (HSD)-A pilot randomised controlled trial of feasibility, acceptability and appropriateness. Eur J Pain. 2025;29(6):e70030.","journal-title":"Eur J Pain"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03937-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:29:07Z","timestamp":1757392147000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03937-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3937"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03937-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Reviewed and approved by the Ethics Committee of the University Hospital of Cologne, Germany (DRKS00024554).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients in this manuscript have given written informed consent to the publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}